PriMatrix is a unique scaffold for the management of wounds that includes diabetic foot ulcers (DFUs). Derived from fetal bovine dermis, this novel acellular dermal matrix provides an ideal environment to support cellular repopulation and revascularization processes critical in wound healing. PriMatrix is particularly rich in Type III collagen, a collagen found in fetal dermis that is active in developing and healing tissues. Recently published clinical data demonstrates that PriMatrix is an adaptable solution to address the most challenging DFUs in a single application. It also further supports PriMatrix’s clinical and economic value to healthcare professionals who are treating patients.
Integra LifeSciences Holdings Corporation